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Collaboration of TLR and non-TLR pathways in innate im-
mune cells, which acts in concert for the induction of in-
flammatory cytokines, can mount a specific adaptive immune 
response tailored to a pathogen. Here, we show that murine 
DC produced increased IL-23 and IL-6 when they were treat-
ed with LPS together with curdlan that activates TLR4 and 
dectin-1, respectively. We also found that the induction of 
the inflammatory cytokine production by LPS and curdlan re-
quires activation of IKK. However, the same treatment did 
not induce DC to produce a sufficient amount of TGF-β. As 
a result, the conditioned media from DC treated with LPS 
and curdlan was not able to direct CD4＋ T cells to Th17 cells. 
Addition of TGF-β but not IL-6 or IL-1β was able to promote 
IL-17 production from CD4＋ T cells. Our results showed that 
although signaling mediated by LPS together with curdlan is 
a potent stimulator of DC to secrete many pro-inflammatory 
cytokines, TGF-β production is a limiting factor for promot-
ing Th17 immunity. 
[Immune Network 2014;14(1):30-37]
 
 
INTRODUCTION
The innate immune system detects infection via germ-line en-
coded receptors which recognize conserved microbial patho-
gen-associated molecular patterns (PAMP) such as lipopoly-
saccharide (LPS) and flagellin (1). Three main groups of pat-
tern recognition receptors are the toll-like receptor (TLR), nu-
cleotide-binding oligomerization domain (NOD)-like receptor 
(NLR) and C-type lectin receptor (2). After recognition of 
PAMP, TLR recruit adaptors such as MyD88 and trigger down-
stream signaling cascades to activate nuclear factor-κB (NF-
κB) and the mitogen-activated protein kinases (MAPK), 
which play a key role in inflammation and immune responses 
by regulating the expression of numerous inflammatory cyto-
kine genes (3). C-type lectin receptors play essential roles in 
recognizing PAMP composed of carbohydrate residues. So 
far, one of the most studied C-type lectin receptors is dec-
tin-1. Dectin-1, the receptor for β-glucan, was shown to be 
required for the control of fungal infection (4-6). Of particular 
interest is that dectin-1-activated dendritic cells (DC) instruct 
IL-17-producing T helper cells (Th17) differentiation (7). 
Dectin-1-activated DC secrete pro-inflammatory cytokines, in-
cluding IL-6, TNF-α and IL-23, but little IL-12 (7).
  Th17 cells have important roles in the pathogenesis of au-
toimmune disease (8). IL-23 was shown to be critically linked 
to autoimmunity after traditionally Th1-associated autoim-
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mune disorders such as experimental autoimmune encephali-
tis (EAE) and collagen-induced arthritis (CIA) have been re-
visited (9). IL-23 is known to promote production of the 
pro-inflammatory cytokine IL-17 from CD4＋ T cells (10). It 
has been shown that IL-23 is required for the terminal differ-
entiation of Th17 cells in vivo (11). However, role of IL-23 
for Th17 commitment is still controversial. Many groups have 
independently found that transforming growth factor-β 
(TGF-β) is necessary for the initiation of Th17 differentiation 
(9,12,13).
  TGF-β is a pleiotropic cytokine with diverse biological ac-
tivity regulating cell proliferation, differentiation, migration 
and survival (14,15). TGF-β is synthesized as a proprotein 
attached to the latency-associated peptide. Converting latent 
TGF-β to an active form is thus a critical regulation mecha-
nism. TGF-β can be activated in vitro by transient acid-
ification or protease treatment. TGF-β inhibits maturation of 
DC and also regulates antigen-presentation (14). Like many 
other cell types, DC also produce TGF-β but the function 
of DC-produced TGF-β remains unclear.
  In this study, we investigated the effect of LPS and curdlan 
on the potential of DC to produce inflammatory cytokines. 
We found that simultaneous activation of TLR4 and Dectin-1 
in DC increased production of pro-inflammatory cytokines in-
cluding IL-23 and IL-6 greater than that by stimulation of each 
pathway alone. However, the same condition did not en-
hance the level of TGF-β, which resulted in poor Th17 
differentiation. Therefore, to induce a potent Th17 cell medi-
ated immune response, TGF-β must be provided by a differ-
ent cell type or stimulation of DC through an additional path-
way is likely required.
MATERIALS AND METHODS
Mice and cells 
IL-10-deficient (Il10－/－) mice were purchased from the 
Jackson Laboratory. C57BL/6 mice were bred and maintained 
under specific pathogen-free conditions at the University of 
Michigan animal facility. All animal procedures were ap-
proved by the University of Michigan Committee on the Use 
and Care of Animals. Bone marrow-derived DC were pre-
pared as previously described (16). MFB-F11 reporter cells 
were kindly provided by Dr. T. Wyss-Coray (Stanford Univer-
sity School of Medicine, Stanford, CA) (17).
Reagents 
LPS was obtained from Sigma-Aldrich. Curdlan was from 
Wako. CpG ODN 1668, lipoteichoic acid (LTA) and PolyI:C 
were purchased from InvivoGen. SB202190, BMS-345541, 
LY294002 and SP600125 were obtained from Calbiochem. 
U0126 was from Promega. Antibodies used for immunoblot 
analysis included p38 MAPK, phospho-p38 MAPK (Tyr180/ 
Tyr182), p44/42 MAPK, phospho-p44/42 MAPK (Thr202/ 
Tyr204), IKKβ, phospho-IKKβ (Ser180)/IKKβ (Ser181), 
SAPK/JNK, phospho-SAPK/JNK (Thr183/Tyr185), phospho- 
TAK1 (Thr184/187), IκBα (Cell Signaling Technology) and 
TAK1 (Santa Cruz Biotechnology). Neutralizing α-IL-10R an-
tibody and isotype control rat IgG1 were purchased from BD 
Pharmingen.
ELISA and quantitative real-time RT-PCR (qRT-PCR) 
Cytokine concentrations in supernatants were detected by 
ELISA and mRNA accumulation of cytokines was analyzed by 
qRT-PCR as previously described (16). TGF-β1 level was 
measured using DuoSet ELISA Development kit (R&D Sys-
tems). Briefly, 0.5 ml of culture supernatants were activated 
by adding 0.1 ml of 1 N HCl and neutralized with 0.1 ml 
of 1.2 N NaOH/0.5 M HEPES to detect total TGF-β1. The 
primers used for Gapdh, Il23a, Il12a, Il12b, Il10 and Il6 were 
described previously (18). The primers used for Il17a were 
5'-GGACTCTCCACCGCAATGA-3' and 5'-GGCACTGAGCTT-
CCCAGATC-3', for Il17f were 5'-CCCCATGGGATTACAACAT 
CAC-3' and 5'-CATTGATGCAGCCTGAGTGTCT-3', for Il22 
were 5'-CATGCAGGAGGTGG TACCTT-3' and 5'-CAGACG-
CAAGCATTTCTCAG-3', for Rorc were 5'-CCGCTGAGAGGG 
CTTCAC-3' and 5'-TGCAGGAGTAGGCCACATTACA-3', for 
Foxp3 were 5'-GGCCCTTCT CCAGGACAGA-3', 5'-GCTGA-
TCATGGCTGGGTTGT-3', for Ifng were 5'-TCAAGTGGCAT 
AGATGTGGAAGAA-3' and 5'-TGGCTCTGCAGGATTT TCATG- 
3', for Tbx21 were 5'-ACAACCCCTTTGCCAAAGGA-3' and 
5'-TCCCCCAAGCAGTTGACAGTT-3' and for Il4 were 5'- 
ACAGGAGAAGGGACGCCAT-3' and 5'-GAAGCCCTA CAGAC-
GAGCTCA-3'. 
Immunoblot analysis 
Cells were lysed in lysis buffer (20 mM Tris-HCl (pH 7.4), 
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2 mM DTT, 1% 
Triton X-100, 1 mM PMSF, 1% protease inhibitor cocktail 
(Sigma-Aldrich) and 25μM MG132). Whole cell lysates were 
boiled in sample buffer (60 mM Tris-HCl (pH 6.8), 25% glyc-
erol, 2% SDS, 5% β-mercaptoethanol and 0.1% bromophenol 
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Figure 1. Co-stimulation of DC with 
LPS and curdlan increased IL-23 
production. (A and B) BMDC pre-
pared from C57BL/6 mice were 
stimulated with LPS (1μg/ml), cur-
dlan (100μg/ml), or both. IL-23 was 
measured by ELISA at 24 h (left 
panels). mRNA levels of IL-23p19 
(middle panels) and IL-12p40 (right 
panels) were determined at the 
indicated time by qRT-PCR. (C) IL-10 
was measured by ELISA (left panel). 
IL-23 was measured by ELISA 
(middle panel). Cells were cotreated 
with LPS and curdlan in the pre-
sence of α-IL-10R (15μg/ml) or rat 
IgG1 (15μg/ml). BMDC prepared 
from C57BL/6 (Il10＋/＋) or Il10－/－
mice were treated with LPS, curdlan, 
or both and IL-23 was measured by 
ELISA (right panel).
blue) and resolved by SDS-PAGE. After transfer to a poly-
vinylidene fluoride (PVDF) membrane (PerkinElmer), proteins 
were probed with the indicated antibodies and visualized by 
enhanced chemiluminescence (Thermo Fisher Scientific).
Preparation and stimulation of CD4＋ T cells 
CD4＋ T cells from C57BL/6 mice were purified using an-
ti-CD4 magnetic beads (Miltenyi Biotec). Bone marrow-de-
rived DC were stimulated with LPS (1μg/ml), curdlan (100μ
g/ml) or both for 24 h. DC culture supernatants (conditioned 
media (CM)) were filtered through 0.2μm Pall Acrodisc sy-
ringe filters and kept at -80oC before adding to the T cell 
culture. 1 ml of CD4＋ T cell (5×105 cells/well) cultures were 
stimulated with plate-bound 5μg/ml of anti-CD3 (2C11) and 
1μg/ ml of anti-CD28 (37-51) in the presence of 2 ml of CM. 
Cultures were restimulated on day 5 with plate-bound an-
ti-CD3. ELISA was performed after 48 h restimulation to de-
tect IL-17A, IFN-γ and IL-4 production. mRNA levels were 
assessed by qRT-PCR after restimulation for 6 h. mRNA ex-
pression in freshly isolated CD4＋ T cells was used as a 
control.
TGF-β bioassay 
The generation of TGF-β reporting cell line (clone MFB-F11) 
and cell-based TGF-β bioassay have been described pre-
viously (17). MFB-F11 cells were maintained in D10 (DMEM 
supplemented with 10% FBS, 100μg/ml penicillin, 100μg/ml 
streptomycin) plus 125μg/ml hygromycin. To determine bio-
active TGF-β, cells were seeded in triplicate at 3×104 
cells/well in 96-well flat-bottom plates in D10. After overnight 
incubation, cells were washed twice with PBS and incubated 
in 50μl of serum-free DMEM media for 2 h. Conditioned me-
dia were added to the cells for 36 h. TGF-β1 (Peprotech) 
or serum-free DMEM was used as a positive or negative con-
trol, respectively. 12.5μl of the culture supernatants were 
collected and SEAP activity was measured using Great EscApe 
SEAP Chemiluminescence Kit 2.0 (Clontech) according to the 
manufacturer’s instructions.
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RESULTS AND DISCUSSION
Co-treatment of DC with LPS and curdlan increased 
IL-23 production 
Stimulation of DC via TLR or dectin-1 pathway was shown 
to elicit the preferential production of IL-12 or IL-23 re-
spectively, which in turn directs Th1 or Th17 differentiation 
of CD4＋ T cells (7). Because an immune system would en-
counter more than one component upon infection, we asked 
whether DC would exhibit a different potential to produce 
cytokines and subsequently induce a different T cell response 
when they are stimulated by both TLR ligand and dectin-1 
agonist simultaneously. To do this, we treated DC with LPS, 
curdlan, or LPS and curdlan together (LPS＋curdlan) and 
measured the level of cytokines in the supernatant. Treatment 
of DC with curdlan alone did not increase IL-23 production 
compared to LPS treatment (Fig. 1A left panel). IL-23 is a het-
erodimer consisting of p19 and p40 protein. mRNA ex-
pression of IL-23p19 and IL-12p40 during the course of cur-
dlan treatment showed that the kinetics of IL-23p19 was grad-
ual and slower than LPS treatment and the expression level 
of IL-12p40 was not increased (Fig. 1A middle and right pan-
els). However, when DC were treated with LPS＋curdlan, we 
observed that IL-23 production was substantially increased 
(Fig. 1B left panel). After co-treatment, mRNA expression of 
both IL-23p19 and IL-12p40 was steadily increased and pro-
longed but declined eventually (Fig. 1B middle and right pan-
els). In addition, we found that IL-10 production was sub-
stantially increased after treating DC with LPS＋curdlan (Fig. 
1C left panel). Because IL-10 is a well-known anti-inflam-
matory cytokine, it is possible that IL-23 production could be 
suppressed by IL-10. If so, blocking IL-10 would further aug-
ment IL-23 induction. Indeed, IL-23 production was greatly 
enhanced when endogenous IL-10 was neutralized by adding 
the anti-IL-10 receptor antibody (α-IL-10R) but not the con-
trol antibody (Fig. 1C middle panel). DC from IL-10-deficient 
(Il10－/－) mice also showed a greater amount of IL-23 when 
they were stimulated with LPS＋curdlan (Fig. 1C right panel). 
Together, co-stimulation of DC via TLR4 and dectin-1 path-
way increased the production of inflammatory cytokines in-
cluding IL-23 and IL-10.
IKK plays an important role in cytokine expression for 
both LPS and curdlan treatment
We then asked which signaling pathways could contribute to 
the increased cytokine production after stimulation of DC 
with LPS＋curdlan. Because LPS and curdlan activate signal-
ing molecules including MAPK and IKK, we used pharmaco-
logical reagents to study the role of MAPK or IKK for the 
expression of cytokine genes. The gene expression of IL-6 
and IL-10 was enhanced by treatment of LPS＋curdlan (Fig. 
2A). When cells were treated with BMS345541 that blocks 
IKKβ, IL-6 and IL-10 gene expression was totally abolished 
(Fig. 2A). In contrast, SP600125, SB202190 and U0126 which 
selectively inhibits JNK, p38 and MEK1/2, respectively, had 
relatively marginal effects on gene expression for both cyto-
kines. Therefore, the results from the inhibitor study suggest 
that NF-κB but not MAPK signaling pathway plays a role 
during activation with LPS＋curdlan. To substantiate this, we 
examined activation of signaling pathways by comparing the 
phosphorylation status of key MAPK and IKK signaling mole-
cules by immunoblot analysis. We found that TAK1 that is 
an upstream kinase responsible for the activation of NF-κB 
and MAPK was activated by LPS but not curdlan. Treating 
DC with LPS＋curdlan further increased TAK1 phosphor-
ylation (Fig. 2B). To identify which downstream signaling 
pathway is activated by TAK1, we first assessed activation of 
IKK. IKKα/β was phosphorylated at the comparable level 
in DC treated with LPS alone or LPS＋curdlan. However, IκB
α degradation was faster in cells stimulated by LPS＋curdlan 
supporting the activation of IKK. In contrast, we did not ob-
serve the similar increase in the phosphorylation status of 
p38, JNK and Erk1/2 by co-treatment of LPS and curdlan (Fig. 
2B). Together, IKK seems to be a key regulator for the in-
duction of inflammatory cytokines in DC upon the engage-
ment of both TLR4 and dectin-1 signaling pathways.
IL-12 production was not increased after cotreat-
ment with LPS and curdlan
IL-12 and IL-23 produced by DC are responsible for promot-
ing Th1 and Th17 cells, respectively. We found that curdlan 
induced little production of IL-12p70 from DC and adding LPS 
＋curdlan did not increase IL-12p70 (Supplementary Fig. 1A). 
This is likely due to the poor transcription of IL-12p35 gene 
by curdlan alone or together with LPS (Supplementary Fig. 
1B). Therefore, treating DC with LPS＋curdlan induces a set 
of inflammatory cytokines particularly those are known to be 
involved in Th17 cell differentiation.
TLR4 and dectin-1 stimulation of DC is not sufficient 
to induce Th17 differentiation
We next investigated whether treatment of DC with LPS＋cur-
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Figure 3. Co-treatment of DC with LPS and curdlan was unable to enhance Th17 differentiation. CD4＋ T cells from C57BL/6 mice were stimulated 
with plate-bound anti-CD3 and anti-CD28 in the presence of conditioned media (CM) as described in the Materials and Methods. CM were 
prepared by treating BMDC with indicated stimulants for 24 h. T cell cultures were then restimulated on day 5 with plate-bound anti-CD3 
for 48 h. ELISA was performed to detect IL-17A, IFN-γ and IL-4 production. *UT: CM from untreated DC.
Figure 2. IKK plays an important role 
in cytokine expression for both LPS 
and curdlan treatment. (A) BMDC 
were pre-treated with indicated in-
hibitors (10μM) for 30 min, fol-
lowed by stimulation with LPS, cur-
dlan, or both for 6 h. IL-6 and IL-10 
mRNA levels were determined by 
qRT-PCR. (B) Cells were treated with 
LPS (1μg/ml), curdlan (100μg/ml), 
or both for the indicated time. P- 
TAK1, TAK1, P-IKKα/β, IKKβ, IκBα, 
P-p38, p38, P-JNK, JNK, P-Erk1/2 
and Erk1/2 were detected by im-
munoblotting.
dlan promotes Th17 differentiation. To test this, DC were 
stimulated with LPS, curdlan, or LPS＋curdlan and the super-
natants (conditioned media; CM) were collected. Three differ-
ent CM was then added to the CD4＋ T cell cultures when 
they were stimulated with anti-CD3 and anti-CD28. Curdlan- 
treated CM induced IL-17A production more than LPS treat-
ment (Fig. 3 left panel). Although LPS＋curdlan treatment of 
DC induced a greater amount of IL-23 and IL-6 than LPS or 
curdlan alone (Fig. 1 and 2), IL-17A production was not en-
hanced by CM from LPS＋curdlan treated DC (Fig. 3 left pan-
el). When LPS or curdlan was added to the T cell culture 
directly, neither promoted IL-17A production suggesting that 
factors produced by DC are required (data not shown). 
Interestingly, curdlan-treated CM induced both IFN-γ and 
IL-4 production greater than LPS-treated CM, but adding CM 
from LPS＋curdlan treated DC suppressed the induction of 
both cytokines (Fig. 3 middle and right panels). Therefore, 
even though DC produced inflammatory cytokines that would 
skew CD4＋ T cells preferentially toward Th17 cells, CM from 
the same condition failed to enhance Th17 cell differentiation.
IL-17 production was enhanced by exogenous 
TGF-β
TGF-β together with IL-6, is considered necessary for IL-17 
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Figure 4. Exogenous TGF-β but not IL-6 nor IL-1β enhanced IL-17 production in co-stimulated DC. (A) BMDC were stimulated with LPS (1 
μg/ml), curdlan (100μg/ml), or both. Total TGF-β1 and bioactive TGF-β were determined as described in the Materials and Methods. *Media:
DC culture media (RPMI+5% serum); UT: CM from untreated DC. (B) CD4+ T cells were stimulated in the presence of CM plus indicated 
cytokines (IL-6 (40 ng/ml), IL-1β (+: 1 ng/ml, ++: 10 ng/ml), TGF-β (+: 2.5 ng/ml, ++: 5 ng/ml, +++: 25 ng/ml)). IL-17A was measured 
by ELISA after anti-CD3 restimulation. (C) CD4+ T cells were stimulated in the presence of CM with or without TGF-β (0.5 ng/ml). Cultures 
were restimulated for 6 h on day 5 with plate-bound anti-CD3 and mRNA levels were assessed by qRT-PCR.
production from CD4＋ T cells (13). Thus, it is possible that 
LPS＋curdlan stimulated DC do not produce sufficient 
amounts of TGF-β, which then would result in a poor re-
sponse of CD4＋ T cells to make IL-17. To test this, we meas-
ured the levels of TGF-β produced by DC upon stimulation 
under the different conditions. As shown in Fig. 4A, the 
amount of total TGF-β1, measured by ELISA after transient 
acid treatment, showed that TGF-β1 was present in all con-
ditions even without stimulation. Moreover, treating DC with 
LPS＋curdlan did not increase the level of TGF-β1 over cur-
dlan alone (Fig. 4A left panel). TGF-β was known to be pro-
duced as a latent form which binds to latency-associated pep-
tide (LAP) (19). Hence, total TGF-β may not accurately rep-
resent its activity. To address this issue, we determined bio-
active TGF-β in CM using a cell-based assay (17). Curdlan 
treated DC produced more active TGF-β than LPS treatment 
but the levels were comparable to LPS＋curdlan treatment 
(Fig. 4A right panel). When we measured active TGF-β pro-
duced by DC, they produced approximately 5 pg (0.2 ng/ml) 
of TGF-β upon LPS＋curdlan treatment (Supplementary Fig. 
2). If the insufficient production of TGF-β caused poor Th17 
differentiation, provision of exogenous TGF-β should gen-
erate a good response of CD4＋ T cells. To test this, we added 
TGF-β together with CM to the CD4＋ T cell cultures. 
Indeed, adding TGF-β but neither IL-6 nor IL-1β to CD4＋ 
T cell cultures enhanced IL-17A production dramatically (Fig. 
4B). The induction of IL-17 was accompanied by the increase 
of mRNA levels of IL-17 family cytokines, IL-17A, IL-17F and 
IL-22 (Fig. 4C). Moreover, RORγt and Foxp3, a key tran-
scription factor for Th17 and regulatory T cell differentiation, 
respectively, were also elevated. However, Tbx21, a master 
transcription factor for Th1 cell differentiation, was not af-
fected by TGF-β(Fig. 4C). Interestingly, TGF-β showed the 
suppressive effect on IFN-γ and IL-4 expression with CM 
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from LPS＋curdlan treatment but not curdlan alone (Fig. 4C). 
Together, our data demonstrated that treating DC with LPS＋
curdlan significantly induces the production of inflammatory 
cytokines but not TGF-β. 
  DC play an important role in priming naïve T cells by pro-
viding cytokines to mount an appropriate adaptive immune 
response tailored to a specific pathogen. For Th17 differ-
entiation, TGF-β, IL-6 and IL-23 are essential to initiate and 
maintain IL-17 gene expression (11,13). Although DC are 
considered as a main source of these cytokines, the current 
study shows that DC do not produce a sufficient amount of 
TGF-β for Th17 cell differentiation. Therefore, it is not yet 
clear how TGF-β is provided. In particular, it remains elu-
sive which cell type(s) could be a source of TGF-β for Th17 
differentiation in vivo. Another possibility is that natural 
pathogens would trigger more than two pattern-recognition 
receptor pathways in DC. If so, activation of an additional 
signaling pathway might induce the expression of TGF-β or 
production of the biologically active form of TGF-β. 
  In conclusion, the present study demonstrated that collabo-
ration of TLR4 and dectin-1 pathways in DC led to the in-
creased production of inflammatory cytokines including IL-23 
and IL-6 known to be important for Th17 cell differentiation. 
However, DC stimulated by LPS＋curdlan were unable to 
promote IL-17 production from CD4＋ T cells due to limited 
TGF-β.
  Future studies are warranted to unveil the combined effects 
of the pattern-recognition receptors and their regulatory me-
chanisms in innate immune cells.
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